why am i not losing weight with tirzepatide Isn't Working: 2026 Guide 7 Reasons You Aren't Losing

The emphasis in internal medicine is on sustainable, evidence-based care rather than quick fixes

In clinical trials, retatrutide has been administered via subcutaneous injection meaning it is injected into the fatty tissue just beneath the skin, rather than into a muscle or vein

In the ATTAIN-MAINTAIN trial, participants transitioning from Wegovy to oral Foundayo (orforglipron) began SURMOUNT-5 at an average body weight of 113.5 kg (250.2 lbs)

The inhibition percentages were analyzed using GraphPad Prism 9.0 and the half maximal inhibitory concentration (IC 50 ) or half maximal effective concentration (EC 50 ) values were determined

And, he added, the people involved in the trials were already taking blood pressure-lowering drugs, platelet aggregation inhibitors, statins, PCSK9 inhibitors, and more

Since the structure of DHAR is not available, the enzymatic mechanism is not well-understood and remains poorly characterized